Jaguar Health Executes Out-License Deal with Joint Venture Magdalena pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.
The drug candidate demonstrates antipsychotic activity and has a mechanism of action distinct from FDA-approved therapies for schizophrenia and other mental conditions that present psychotic symptomsJaguar
Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Jaguar Health (NASDAQ:JAGX – Free Report) in a research note published on Friday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Jaguar Health Price Performance Shares of NASDAQ JAGX opened at $4.63 on Friday. The business has a 50-day moving average price of $9.62 and […]
SAN FRANCISCO, CA / ACCESSWIRE / May 28, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") family company Napo Pharmaceuticals ("Napo") today announced that the results of a third-party, investigator-initiated